Amfenac Sodium Monohydrate
CAS No. 61618-27-7
Amfenac Sodium Monohydrate ( Amfenac sodium H2O )
产品货号. M15326 CAS No. 61618-27-7
Amfenac Sodium Hydrate 是一个 COX-2 抑制剂。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 10MG | ¥103 | 有现货 |
|
| 25MG | ¥166 | 有现货 |
|
| 50MG | ¥240 | 有现货 |
|
| 100MG | ¥340 | 有现货 |
|
| 500MG | ¥821 | 有现货 |
|
| 1G | ¥1197 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥116 | 有现货 |
|
生物学信息
-
产品名称Amfenac Sodium Monohydrate
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Amfenac Sodium Hydrate 是一个 COX-2 抑制剂。
-
产品描述Amfenac Sodium monohydrate is a non-steroidal analgesic anti-inflammatory drug with acetic acid moiety.(In Vitro):Cells transfected to express COX-2 have a higher proliferation rate than those do not. The addition of Amfenac Sodium Hydrate significantly decreases the proliferation rate of all cell lines. Nitric oxide production by macrophages is inhibited by the addition of melanoma conditioned medium, the addition of Amfenac Sodium Hydrate partially overcomes this inhibition. Results show that Amfenac Sodium Hydrate inhibits the release of B-glucuronidase: 5×10-4 M Amfenac Sodium Hydrate inhibits the release of the enzyme 35.3 and 16.3% in the presence of 10-8, and 10-7 M FMLP, respectively. Addition of 10-4 M Amfenac Sodium Hydrate causes 28.3% inhibition of aggregation of polgmorphonuclear leukocgtes (PMNs) during incubation for 16 min with 10-8 M FMLP.
-
体外实验Cells transfected to express COX-2 have a higher proliferation rate than those do not. The addition of Amfenac Sodium Hydrate significantly decreases the proliferation rate of all cell lines. Nitric oxide production by macrophages is inhibited by the addition of melanoma conditioned medium, the addition of Amfenac Sodium Hydrate partially overcomes this inhibition. Results show that Amfenac Sodium Hydrate inhibits the release of B-glucuronidase: 5×10-4 M Amfenac Sodium Hydrate inhibits the release of the enzyme 35.3 and 16.3% in the presence of 10-8, and 10-7 M FMLP, respectively. Addition of 10-4 M Amfenac Sodium Hydrate causes 28.3% inhibition of aggregation of polgmorphonuclear leukocgtes (PMNs) during incubation for 16 min with 10-8 M FMLP.
-
体内实验——
-
同义词Amfenac sodium H2O
-
通路Chromatin/Epigenetic
-
靶点COX
-
受体COX-1| COX-2
-
研究领域Other Indications
-
适应症——
化学信息
-
CAS Number61618-27-7
-
分子量295.27
-
分子式C15H12NO3·H2O·Na
-
纯度>98% (HPLC)
-
溶解度Ethanol: 4 mg/mL (13.54 mM); Water: 59 mg/mL (199.81 mM); DMSO: 59 mg/mL (199.81 mM)
-
SMILESO=C([O-])CC1=CC=CC(C(C2=CC=CC=C2)=O)=C1N.[H]O[H].[Na+]
-
化学全称Benzeneacetic acid, 2-amino-3-benzoyl-, sodium salt, monohydrate
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Gamache DA, et al. Inflammation, 2000, 24(4), 357-370.
产品手册
关联产品
-
Suxibuzone
Suxibuzone 是一种用于治疗关节和肌肉疼痛的化合物。它是非甾体类抗炎药保泰松的前药。
-
Paeoniflorin
芍药甙是从芍药(Paeonia albiflora Pall)根中提取的草本成分。
-
BN-82451 2HCl
BN-82451 2HCl is a dual inhibitor of COX-1 and COX-2 and can be used to study Huntington's chorea and Parkinson's disease.
021-51111890
购物车()
sales@molnova.cn

